November 25, 2026· Filed
Name in SEC filings: Sanofi
SNY · 1 program · Next stated timing: “November 25, 2026” · Earlier SEC wording is retained below.
| Program | Event | Stage | Stated timing | Filing |
|---|---|---|---|---|
| venglustat | FDA goal date (company stated) | November 25, 2026 | 6-K · |
Source: ORION, orionbiotechai.com/company/SNY, data as of Oct 29, 2026
https://www.orionbiotechai.com/company/SNY
venglustat · FDA goal date (company stated) · November 25, 2026
SEC sources last checked .
No full company check on record. The date above is the newest check of a single row.
○ Quote matched to filing (not yet reviewed by founder) · ✓ Checked by founder.
type 3 Gaucher disease (GD3)
FDA goal date (company stated)November 25, 2026
Stage: PDUFASEC filing · “target action date”
Public float: Unknown (no public float found in SEC filings).
The target action date for the FDA decision is November 25, 2026.
6-K · Filed · Source rechecked
Dots are filing dates. Bars show resolved calendar periods; timing wording stays as stated.
Sources: EX-99.1 filed Jun 8, 2026; EX-99.1 filed Jul 30, 2026.
Company periods and sentences are quoted as written. A matching disclosure uses the SEC filing date for the same program and event type. As of .
| Program / event | Stated period and SEC wording | Disclosure in stated period |
|---|---|---|
| venglustatFDA decision | November 25, 2026“The target action date for the FDA decision is November 25, 2026.” Filed · EX-99.1 | Period not started The stated period has not started yet, so there is nothing to compare. |
| venglustatFDA decision | November 25, 2026“The target action date for the FDA decision is November 25, 2026.” Filed · EX-99.1 | Period not started The stated period has not started yet, so there is nothing to compare. |
“Not compared” means ORION has not matched this wording against a complete set of SEC filings for its period. It says nothing either way about whether a matching filing exists. Wording without exact dates is not given calendar dates.
Exact dates stated in SEC filings appear as single all-day entries with the company’s sentence as written and its SEC link. Periods and date bounds remain in the company records and are not added to calendars. An entry is updated when the company’s timing wording changes; if newer wording gives no exact date, the entry is removed.
Apple Calendar · Add to Google Calendar · Download SNY.ics
Calendar address: https://www.orionbiotechai.com/company/SNY.ics
Google Calendar: on a computer, open Google Calendar, then Settings, Add calendar, From URL. Paste the calendar address and choose Add calendar. The phone apps cannot add a calendar by address. Google refreshes subscribed calendars on its own schedule, which can take a day or more.
Apple Calendar on a Mac: choose File, then New Calendar Subscription, and paste the address. Set Location to iCloud to see it on iPhone, and pick an Auto-refresh interval. On iPhone or iPad with iOS 18 or later: Settings, Apps, Calendar, Calendar Accounts, Add Account, Other, Add Subscribed Calendar. On iOS 17 or earlier: Settings, Calendar, Accounts, Add Account, Other, Add Subscribed Calendar.
Outlook on the web or the new Outlook: choose Add calendar, then Subscribe from web, paste the address, name it and choose Import. Classic Outlook for Windows: Home, Add Calendar, From Internet, then paste the address.
Entries are single all-day items on exact dates the company named and are marked as free time. The download link saves a copy that does not update; use the address for a subscription.
No sign-up and no email address. Links back to ORION carry ?src=ics or ?src=rss and nothing else.
Suggest an SEC timing statement to add for SNY. You can include the original filing link in your note. The founder reads each request by hand.
Or email ORION.
See SNY in the calendar · Review labels and methodology